Biologic Videos

  1. Boehringer Ingelheim Capabilities Update March 2026: Large Molecule 3/10/2026

    Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.

  2. LNP And Liposomal Center Of Excellence 3/10/2026

    A connected development pathway supports smoother scale-up and greater consistency for LNP-based therapeutics. Explore how integrated expertise across key stages helps teams accelerate progress.

  3. Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing 3/8/2026

    Uncover how data-driven process design, effective technology transfer, and robust process characterization can accelerate validation readiness and help move biologics from development to commercial success faster.

  4. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

  5. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

  6. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

  7. USP <665> Compliance Guidance 2/26/2026

    Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.

  8. Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields 2/26/2026

    Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

  9. Integrated Thinking for Complex FIH Programs 2/25/2026

    See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.

  10. How To Implement Pre-Use Post-Sterilization Integrity Testing (PUPSIT) Without The Pain 2/25/2026

    Discover how patented valve design and visual guidance systems simplify PUPSIT setup while reducing risks of incorrect assembly and operator error during sterile filtration operations.